Neogenomics Inc (NEO) 8.72 $NEO How These Healthcare

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 8:07 AM

Neogenomics Inc (NEO) 8.72 $NEO

How These Healthcare Stocks are Performing? -- AMAG Pharma, IDEXX Laboratories, Neogenomics, and ICON
PR Newswire - Fri Jul 29, 7:50AM CDT
The Healthcare sector remains one of the most stable industries in the market, unfazed by economic conditions and uncertainties. While the industry faces issues with cost pressures, ransomware risks, and existing policies, several companies remain unscathed and continue to impress with significant returns. Stocks to evaluate today on Stock-Callers.com are AMAG Pharmaceuticals Inc. (NASDAQ: AMAG), IDEXX Laboratories Inc. (NASDAQ: IDXX), Neogenomics Inc. (NASDAQ: NEO), and ICON PLC (NASDAQ: ICLR). Learn more about these stocks by accessing their free notes at:
NEO: 8.72 (-0.40), AMAG: 26.53 (-0.06), IDXX: 93.79 (+0.58), ICLR: 77.67 (-1.02)

NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016
PR Newswire - Tue Jul 26, 6:00AM CDT
NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the second quarter of 2016.
NEO: 8.72 (-0.40)

Investor Calendar Invites You to the NeoGenomics Second Quarter 2016 Earnings Conference Call and Webcast Live on Tuesday, July 26, 2016
ACCESSWIRE - Mon Jul 25, 3:11PM CDT
FORT MYERS, FL / ACCESSWIRE / July 25, 2016 / NeoGenomics, Inc. (NASDAQ: NEO) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Tuesday, July 26, 2016 at 11:00 AM Eastern Time.
NEO: 8.72 (-0.40)

What's in Store for these 5 Drug Stocks in Q2 Earnings?
Arpita Dutt - Zacks Investment Research - Mon Jul 25, 7:24AM CDT
Medical stocks are once again expected be among the better performers in Q2. Johnson & Johnson (JNJ) and Biogen have already set the tone with beats and raised outlooks.
MDVN: 63.99 (+1.50), BIIB: 289.93 (+0.90), JNJ: 125.23 (+0.77), ALDR: 32.10 (+1.57), SGEN: 48.06 (+0.69), NEO: 8.72 (-0.40), EXAS: 17.38 (+0.06)

Fate Therapeutics (FATE) Catches Eye: Stock Jumps 19.1%
Zacks Equity Research - Zacks Investment Research - Tue Jun 21, 7:25AM CDT
Fate Therapeutics, Inc. (FATE) moved big last session, as its shares jumped over 19% on the day.
FATE: 2.07 (+0.09), NEO: 8.72 (-0.40)

Zacks Investment Ideas feature highlights: Neogenomics, AMN Healthcare Services, Glaukos, National Commerce and NMI Holdings
Zacks Equity Research - Zacks Investment Research - Mon Jun 20, 8:30AM CDT
Zacks Investment Ideas feature highlights: Neogenomics, AMN Healthcare Services, Glaukos, National Commerce and NMI Holdings
GKOS: 34.96 (+0.21), NEO: 8.72 (-0.40), NCOM: 24.31 (unch), AHS: 42.30 (-1.07)

5 Great Growth Stocks To Buy Now
Brian Bolan - ZACKS - Fri Jun 17, 12:57PM CDT
5 Great Growth Stocks To Buy Now
GKOS: 34.96 (+0.21), NEO: 8.72 (-0.40), NCOM: 24.31 (unch), AHS: 42.30 (-1.07), NMIH: 6.28 (+0.01)

Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
Zacks Equity Research - Zacks Investment Research - Fri Jun 17, 8:30AM CDT
Zacks.com featured highlights: United Natural Foods, Weight Watchers International, PharMerica, Boardwalk Pipeline Partners and Neogenomics
PMC: 26.56 (+0.25), UNFI: 49.98 (+0.48), NEO: 8.72 (-0.40), BWP: 16.71 (+0.29), WTW: 11.93 (+0.45)

Bet on These 5 Stocks with Upgraded Broker Ratings
Zacks Equity Research - Zacks Investment Research - Thu Jun 16, 8:14AM CDT
After thorough research, brokers decide to rate that particular company's stock. Naturally, when an analyst upgrades a stock, you can easily rely on it.
PMC: 26.56 (+0.25), UNFI: 49.98 (+0.48), NEO: 8.72 (-0.40), BWP: 16.71 (+0.29), WTW: 11.93 (+0.45)

Neogenomics (NEO) Sees Hammer Chart Pattern: Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 8:54AM CDT
Neogenomics Inc. (NEO) has been struggling lately, but the selling pressure may be coming to an end soon
NEO: 8.72 (-0.40)

Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 8:30AM CDT
Zacks.com featured expert Kevin Matras highlights: Commercial Vehicle Group, Neogenomics and NetEase
NTES: 204.27 (-1.76), NEO: 8.72 (-0.40), CVGI: 4.14 (+0.23)

Explosive Returns with the Filtered Zacks Rank 5 Strategy
Kevin Matras - ZACKS - Tue Jun 07, 3:38PM CDT
Explosive Returns with the Filtered Zacks Rank 5 Strategy
NTES: 204.27 (-1.76), NEO: 8.72 (-0.40), CVGI: 4.14 (+0.23)

Bet on These 5 Liquid Stocks for Fat Returns
Zacks Equity Research - Zacks Investment Research - Mon Jun 06, 12:23PM CDT
An efficient company with a favorable liquidity level may prove to be a profitable addition to one's portfolio.
NEO: 8.72 (-0.40), SLAB: 53.28 (-0.84), NTGR: 51.43 (-0.92), LPLA: 26.95 (+1.69), AMPH: 16.18 (-0.09)

The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
Zacks Equity Research - Zacks Investment Research - Fri Jun 03, 8:30AM CDT
The Zacks Analyst Blog Highlights: Health Insurance Innovations, AMN Healthcare Services, Neogenomics, Amerisafe and CoStar Group
CSGP: 207.90 (+0.70), AMSF: 58.53 (-3.15), NEO: 8.72 (-0.40), HIIQ: 4.00 (unch), AHS: 42.30 (-1.07)

7 Stocks with Recent Price Strength to Boost Your Returns
Zacks Equity Research - Zacks Investment Research - Thu Jun 02, 9:24AM CDT
Stocks that have recently seen price strength have high chances of carrying the momentum forward.
AMSF: 58.53 (-3.15), NEO: 8.72 (-0.40), HIIQ: 4.00 (unch), AHS: 42.30 (-1.07), COHR: 106.05 (+2.30), NANO: 20.04 (-0.48)

Integra (IART): Strong Revenue Growth on Global Prospects
Zacks Equity Research - Zacks Investment Research - Wed Jun 01, 7:16AM CDT
On May 31, 2016, we issued an updated research report on Plainsboro, NJ-based Integra LifeSciences Holdings Corporation (IART).
IART: 84.27 (+1.30), ANIP: 60.60 (+0.99), NEO: 8.72 (-0.40), RTRX: 17.93 (+0.40)

Earnings Estimates Moving Higher for Neogenomics (NEO): Time to Buy?
Zacks Equity Research - Zacks Investment Research - Thu May 26, 7:42AM CDT
Neogenomics (NEO) could be an interesting play for investors as it is seeing solid activity on the earnings estimate revision.
NEO: 8.72 (-0.40)

Integra Unveils Fin-Lock Glenoid, Boosts Shoulder Arthroplasty
Zacks Equity Research - Zacks Investment Research - Tue May 24, 7:22AM CDT
Integra LifeSciences Holdings Corporation (IART) recently launched Integra Fin-Lock Glenoid.
IART: 84.27 (+1.30), HSKA: 42.55 (+0.03), ANIP: 60.60 (+0.99), NEO: 8.72 (-0.40)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Coventry's Jacobs Joins European Life Settlement Execs

Neal Jacobs Steps Up in Life Settlements Coventry has added another feather to its cap with Neal Jacobs, their Senior Managing Director of Capital Markets, joining the Executive Committee of the European Life Settlement Association (ELSA). Elected at ELSA's Annual General Meeting on September 15, 2026, Jacobs brings a wealth of experience that promises to bolster the...

Celebree Gains Franchise Momentum: A New Frontier

The Climb: Celebree Schools on the Rise Here's a nugget in the franchise world that's causing a stir: Celebree School is making moves up the Franchise Times Top 400. When we're talking about a hop, skip, and jump through 84 spots since 2023, you can't help but notice. It's the third year in a row they're climbing this ladder, and it's making ripples. Franchise Expansion...

OmniActive's Fenavari: A New Era in Women's Health

Pioneering Women's Health with Fenavari You ever wonder why some health products get all the hype? Here's one for the book: OmniActive Health Technologies launching Fenavari, their top-tier contender in the women's health market. Now, we're not talking your run-of-the-mill supplement here. We're stepping onto a new playing field, especially with Dr. Taz Bhatia stepping...

Skiptown Expands in Georgia Amid Growing Demand

With the pet care industry barking up a storm lately, Skiptown is ramping up efforts to expand its presence in Georgia. The tech-enabled dog care franchise already has a paw print in Atlanta, but it's sniffing out new opportunities across the state. Now they're on the hunt for franchise owners who can bring this modern approach to more communities. Why Georgia? The Growth...

Veterans Transitioning to Real Estate with Scholarships

Tapping Military Skills for Civilian Gain Finding a new career after military service is a mountain of a task, but veterans now have a golden ticket into the real estate appraisal world. The Appraisal Institute's Next Mission Scholarship is throwing veterans a $1,000 life preserver to dive into a field where their military-honed skills already shine. The Power of a...

Fluence Energy Faces Major Lawsuit Amid $3B Loss

Securities Class Action: A Storm Brewing Just when you think you've got a grip on the market, a sharp right hook can come out of nowhere. Fluence Energy (NASDAQ:FLNC) is dealing with one of those punches now, getting dragged into the courtroom over claims they fudged financial lines. They hail innovation in energy storage, but shareholders are left shaking in their boots...

CMC Declares Dividend Amid Complex Outlook

Dividend's Not Just a Regular Check October 13, 2026, marks yet another dividend declaration by CMC. This time, they're dishing out $0.20 per share—a steady payday for loyal shareholders. That's 248 times in a row they've done this song and dance. Odds are, folks holding NYSE:CMC shares are giving the nod of approval, but it ain't just about cash; it's about stability...

Think Tank Pushes for Bold Parkinson's Prevention Plan

A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...

TechCrunch Disrupt 2026: NYSE and Snowflake Highlights

Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...

Omneky Outshines Competitors in AI Ad Scoring

Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...